| |
COMPOSITION
Each chewable tablet contains 100 mg Iron as
Ferric hydroxide-polymaltose complex. Each teaspoonful (5ml) syrup
contains 50mg of Iron as Ferric hydroxide-polymaltose complex. |
| |
PROPERTIES
Iron polymaltose as present in Ferose tablets
and syrup provides an ideal preparation for all iron deficiency anemias.
It is rapidly absorbed, with a high rate of iron utilization and produces
an effective increase in Haemoglobin. Due to its favourable non-ionic
nature it has the following properties unlike ionised iron salt preparations:
• Ferose does not give rise to irritation of the intestinal mucosa
and does not stain the teeth.
• Ferose has palatable, non metallic taste (Ferose chewable tablets
have chocolate flavour and are acceptable even by the most resistant
patients of all ages).
• Ferose has excellent tolerance. |
| |
INDICATIONS
Prevention and treatment of all kinds of iron
deficiencies, particularly iron deficiency anemia. |
| |
DOSAGE
AND ADMINISTRATION
Adults and children over 12 years :
tablets : in normal cases 1 tablet daily chewed or swallowed with
some liquid during or after meals. If required the dosage is increased
to 1 tablet twice daily, as per physician's prescription. Syrup :
2 teaspoonful 1 - 2 times daily during or after meals. Children under
12 years :
Syrup : 1 teaspoonful 1 - 2 times daily during or after meals. Infants
: Begin with 1/2 of a teaspoonful daily and increase to 1 teaspoonful
daily. Ferose Syrup may be mixed with fruits or vegetable juices or
other liquid if desired. |
| |
CONTRA-INDICATIONS
– Disturbances in iron utilization (lead anemia),
Thalassemia.
– Hypersensitivity or intolerance to iron and overloading of iron
in the body.
– Anemia not caused by iron deficiency. |
| |
PRECAUTIONS
As with all iron preparations, a dark colouration
of the stool may occur which is without clinical significance. |
| |
PREGNANCY
AND LACTATION
Reproduction studies in animals did not show
any foetal risk. Controlled studies in pregnant women after the first
trimester have not shown any undesirable effects on mother and neonates.
There is no evidence of a risk during the first trimester and the
possibility of a negative influence to the foetus is unlikely to occur.
Mother's milk contains iron bound to lactoferrin. It is not known
how much iron from the complex is passed into mother's milk. The administration
of Ferose¨ is unlikely to cause undesirable effects to the nursed
child. |
| |
UNDESIRABLE EFFECTS
Occasionally gastrointestinal irritations such
as sensation of repletion, pressure in the epigastric region, nausea,
constipation or diarrhoea can occur. |
| |
INTERACTIONS
There is no interaction between Ferose and food
or between Ferose and drugs due to its non ionic nature. |
| |
PRESENTATIONS
Ferose is available as tablets, syrup and Drops.
|
